Project Grant R01DA062632
Award Date
8/1/25
Completion Date
5/31/30
Dollars Obligated
$753K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Oklahoma City, OK, USA
Similar Awards
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will provide $431,750 to Rutgers, The State University of New Jersey to conduct a multi-method investigation of premium cigar use and marketing. The key objectives are to: 1) understand consumer experiences and perceptions of premium cigars through focus groups; 2) document and characterize premium cigar marketing through a longitudinal content...
This federal Project Grant award, funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research on the impact of little cigars and cigarillos (LCCs) on the co-use of multiple tobacco products and cannabis in young adults. The award, totaling $176,455.00, will be provided to Case Western Reserve University (CWRU) over a 5-year period from August 1, 2025 to July 31, 2030. The research aims to build the candidate's...
This Project Grant award of $622,957 from the National Institutes of Health (NIH) Office of the Director, under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077), supports research by Duke University to investigate the chemical composition and behavioral effects of novel tobacco products, including oral nicotine pouches and "non-menthol" cigarettes. The study aims to analyze the flavors, sweeteners, and nicotine forms in these products, and...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will fund research to study the neurogenetic mechanisms underlying nicotine and cannabis addiction. The $175,888 award, effective September 1, 2024 through August 31, 2028, will enable the development of novel transcriptome-connectome analysis methods to identify genes associated with changes in brain functional connectivity related to addiction. The...
The National Institutes of Health (NIH) Office of the Director awarded a $1,197,896 Project Grant under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077) to the University of Oklahoma Health Sciences Center. The objective of this 5-year longitudinal study is to use traditional survey methods combined with ecological momentary assessment (EMA) to better understand the impact of electronic nicotine delivery system (ENDS) product characteristics on...
The National Institute on Drug Abuse (NIDA) awarded a $863,837 Project Grant under CFDA 93.279 (Drug Use and Addiction Research Programs) to the National Opinion Research Center (NORC) to study the effects of alternative tobacco product marketing on social media platforms like Instagram, Facebook, and TikTok, and its impact on tobacco use among youth and young adults. The project aims to: 1) identify and characterize social media content related to alternative tobacco products, 2) assess the...
This $2,353,743 Project Grant awarded by the National Institutes of Health (NIH) under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077) will support research on the prevalence and effects of "natural" descriptors used in cigar packaging. The project aims to: 1) analyze Nielsen cigar sales data and purchased cigar packs to examine the use of "natural" themed descriptors and imagery on cigar packaging over time, 2) test the effects...
This federal Project Grant award, funded by the National Institute on Drug Abuse (NIDA) under CFDA 93.279 - Drug Use and Addiction Research Programs, provides $353,508 to Clemson University to conduct a 3-group randomized controlled trial examining the impact of electronic cigarette (EC) flavor and use patterns on harm reduction milestones (e.g., cigarette per day reduction, switching) among people with opioid use disorder on buprenorphine. The 5-year project aims to offer the principal...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $395,566 to Flik Therapeutics, Inc. to support the development of a novel FDA-regulated pharmacotherapy and multimodal nicotine cessation program. The goal is to create a more effective smoking cessation therapy compared to the current standard of care, which has low success rates. This Phase I proposal will fund the initial development of the...
This federal Project Grant award of $360,100.00 was provided by the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), to George Washington University. The funding will support research on the "Socio-Structural Determinants of Cannabis and Derived Psychoactive Cannabis Product Use and Consequences Among Young Adults." The project aims to investigate the increasing use of cannabis and derived psychoactive cannabis products,...